Page last updated: 2024-10-25

ciprofloxacin and Gastroenteritis

ciprofloxacin has been researched along with Gastroenteritis in 44 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Gastroenteritis: INFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER.

Research Excerpts

ExcerptRelevanceReference
"We conducted a randomized controlled trial to determine whether empirical treatment of severe acute community-acquired gastroenteritis (four fluid stools per day for > 3 days) with ciprofloxacin reduces the duration of diarrhea and other symptoms and to determine what effect ciprofloxacin has on the duration of long-term fecal carriage of gastrointestinal pathogens."9.08Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. ( Dryden, MS; Gabb, RJ; Wright, SK, 1996)
"In this patient, intracystic infusion of ciprofloxacin achieved a sufficient antibiotic level in infected renal cysts and hence completely eradicated S."7.78Refractory Salmonella enterica serotype choleraesuis-related renal cyst infection in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis treated successfully with intracystic ciprofloxacin infusion. ( Chen, JB; Chuang, FR; Lee, CH; Lee, CT; Wu, CH; Yang, CC, 2012)
"We audited the use of ciprofloxacin, before and after the introduction of simple clinical guidelines, in adults admitted to a regional infectious diseases unit with presumed gastroenteritis."7.69Clinical audit of ciprofloxacin use in adults admitted to hospital with gastroenteritis. ( Beeching, NJ; Fox, R; Nye, FJ; Taylor, A, 1996)
"Five days' ciprofloxacin treatment resulted quick clinical improvement in all of the 45 patients with salmonella gastroenteritis and stool cultures of 35 patients became negative."6.17[Experience with ciprofloxacin therapy of salmonellosis gastroenteritica]. ( Bíró, L; Rókusz, L; Szepesi, A; Várszegi, J, 1992)
"Although campylobacteriosis is usually a self-limited infection, antibiotics are indicated for severe and chronic conditions."5.48Genetic diversity and clonal characteristics of ciprofloxacin-resistant Campylobacter jejuni isolated from Chilean patients with gastroenteritis. ( Collado, L; Muñoz, I; Muñoz, N; Ochoa, S; Porte, L; Varela, C, 2018)
"Ulifloxacin was highly active against Escherichia coli, Salmonella spp."5.35Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea. ( Biedenbach, DJ; Fritsche, TR; Jones, RN, 2009)
"We conducted a randomized controlled trial to determine whether empirical treatment of severe acute community-acquired gastroenteritis (four fluid stools per day for > 3 days) with ciprofloxacin reduces the duration of diarrhea and other symptoms and to determine what effect ciprofloxacin has on the duration of long-term fecal carriage of gastrointestinal pathogens."5.08Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. ( Dryden, MS; Gabb, RJ; Wright, SK, 1996)
"At the Clinic for infectious and dermatovenerologic diseases in Novi Sad a prospective randomized, simple, blind investigation of differently organized treatments of salmonellal gastroenterocolitis (symptomatic therapies, ampicillin, co-trimoxazole and ciprofloxacine) was carried out."5.07[Therapy of salmonella gastroenterocolitis]. ( Brkić, S; Celanović, M; Jovanović, J; Knezević, K; Madle-Samardzija, N, 1994)
"This study was aimed at investigating the occurrence and genetic mechanisms of resistance to ciprofloxacin, tetracycline and erythromycin in clinical isolates of Campylobacter jejuni recovered from human cases of acute gastroenteritis in Turkey."3.91Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey. ( Abay, S; Aydin, F; Kayman, T; Şahin, O, 2019)
"Ciprofloxacin is recognized to have a deleterious relationship with tendons, particularly Achilles tendinopathy, which makes up most case reports."3.88Two Unique Cases of Ciprofloxacin-Associated Avulsion of Ligament and Tendon. ( Irwin, RW; Smith, JD; Wolff, ET, 2018)
"In this patient, intracystic infusion of ciprofloxacin achieved a sufficient antibiotic level in infected renal cysts and hence completely eradicated S."3.78Refractory Salmonella enterica serotype choleraesuis-related renal cyst infection in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis treated successfully with intracystic ciprofloxacin infusion. ( Chen, JB; Chuang, FR; Lee, CH; Lee, CT; Wu, CH; Yang, CC, 2012)
" We report on a 17-year-old immunocompetent female patient, hospitalized with Salmonella braenderup gastroenteritis and splenic abscess, who was treated with ciprofloxacin, percutaneous catheter drainage and despite remaining drainage of 50 ml/24 h, the catheter was removed and the antibiotic treatment was stopped when the fluid was clear."3.69Splenic abscess caused by Salmonella braenderup, treated with percutaneous drainage and antibiotics. ( Rørbakken, G; Schulz, T, 1997)
"Although campylobacteriosis is usually a self-limited infection, antibiotics are indicated for severe and chronic conditions."1.48Genetic diversity and clonal characteristics of ciprofloxacin-resistant Campylobacter jejuni isolated from Chilean patients with gastroenteritis. ( Collado, L; Muñoz, I; Muñoz, N; Ochoa, S; Porte, L; Varela, C, 2018)
"Ciprofloxacin was given to 97% patients along with fluid administration, and 78% were found to be resistant to quinolones."1.38Clinical characteristics and predictors of positive stool culture in adult patients with acute gastroenteritis. ( Anwar, MA; Awan, S; Hilal, H; Khan, MS; Patel, MJ; Razi, S; Riaz, MM; Tariq, M, 2012)
"Sweet's syndrome or acute febrile neutrophilic dermatosis has been associated with underlying infection, malignancy, inflammatory disease and certain medications."1.38Campylobacter gastroenteritis associated with Sweet's syndrome. ( Aliyu, SH; Karas, JA; Pai, S; Rytina, E; Sterling, J, 2012)
"Ulifloxacin was highly active against Escherichia coli, Salmonella spp."1.35Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea. ( Biedenbach, DJ; Fritsche, TR; Jones, RN, 2009)
"The proven shigellosis as well as the strong suspicion have to be treated promptly with antibiotics, mainly azithromycin."1.35[Bacterial diarrheas and antibiotics: European recommendations]. ( Cohen, R; Gendrel, D, 2008)
"Treatment with ciprofloxacin appeared to accelerate recovery from severe or persistent diarrhoea due to this organism."1.28Treatment of symptomatic enteric aeromonas hydrophila infection with ciprofloxacin. ( Harvey, G; Laing, RB; Nathwani, D; Smith, CC, 1991)
"Ciprofloxacin was used successfully in two outbreaks of salmonella gastroenteritis at a dose of 500 mg bd orally for seven days."1.28Management of institutional outbreaks of Salmonella gastroenteritis. ( Ahmad, F; Cowden, J; Lightfoot, NF, 1990)

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.27)18.7374
1990's14 (31.82)18.2507
2000's11 (25.00)29.6817
2010's16 (36.36)24.3611
2020's2 (4.55)2.80

Authors

AuthorsStudies
Fritsche, TR1
Biedenbach, DJ1
Jones, RN1
Hizlisoy, H1
Sagiroglu, P1
Barel, M1
Dishan, A1
Gungor, C1
Koskeroglu, K1
Hizlisoy, S1
Atalay, MA1
Moharana, SS1
Panda, RK1
Dash, M1
Chayani, N1
Bokade, P1
Pati, S1
Bhattacharya, D1
Forson, AO1
Adjei, DN1
Olu-Taiwo, M1
Quarchie, MN1
Asmah, HR1
Smith, JD1
Irwin, RW1
Wolff, ET1
Fardsanei, F1
Soltan Dallal, MM1
Douraghi, M1
Memariani, H1
Bakhshi, B1
Zahraei Salehi, T1
Nikkhahi, F1
Collado, L1
Muñoz, N1
Porte, L2
Ochoa, S1
Varela, C1
Muñoz, I1
Kayman, T1
Abay, S1
Aydin, F1
Şahin, O2
Abbasi, E1
van Belkum, A1
Ghaznavi-Rad, E1
Ranjan, A1
Praharaj, SK1
Mahmood, A1
Al Hakawati, MI1
Lübbert, C1
Shen, Z1
Zhang, Q1
Gendrel, D1
Cohen, R1
Lunn, AD1
Fàbrega, A1
Sánchez-Céspedes, J1
Vila, J1
Ulloa F, MT1
Braun J, S1
Dabanch P, J1
Fica C, A1
Henríquez A, T1
Osorio A, CG1
Riaz, MM1
Patel, MJ1
Khan, MS1
Anwar, MA1
Tariq, M1
Hilal, H1
Awan, S1
Razi, S1
Yang, CC1
Chuang, FR1
Wu, CH1
Chen, JB1
Lee, CH1
Lee, CT1
Pai, S1
Rytina, E1
Sterling, J1
Karas, JA1
Aliyu, SH1
Leung, DT1
Das, SK1
Malek, MA1
Ahmed, D1
Khanam, F1
Qadri, F1
Faruque, AS1
Ryan, ET1
Nachamkin, I1
Ung, H1
Li, M1
Hsu, RB1
Chen, RJ1
Lin, FY1
Chu, SH1
Bischoff, A1
Fitch, BR1
Sachen, KL1
Wilder, SR1
Burg, MA1
Lacher, DW1
Khalife, WT1
Whittam, TS1
Young, VB1
Lehtopolku, M1
Hakanen, AJ2
Siitonen, A2
Huovinen, P2
Kotilainen, P2
Pitkänen, S1
Huikko, S1
van Hees, BC1
de Ruiter, E1
Wiltink, EH1
de Jongh, BM1
Tersmette, M1
Friesen, C1
Hill, I1
Woods, C1
Sire, JM1
Garin, B1
Macondo, EA1
Diez-Enciso, M1
Mas-Jimenez, G1
Velasco-Cerrudo, A1
Gutierrez-Altes, A1
Brkić, S1
Knezević, K1
Celanović, M1
Jovanović, J1
Madle-Samardzija, N1
Elcuaz, R1
Lluch-Perales, JF1
Gómez, E1
Suárez, J1
Hernández, M1
LaFarga, B1
Funke, G1
Nemes, P1
Lüthy-Hottenstein, J1
Altwegg, M1
Dryden, MS1
Gabb, RJ1
Wright, SK1
Fox, R1
Taylor, A1
Beeching, NJ1
Nye, FJ1
Laing, RB2
Lee, C1
Leen, CL1
Segura Porta, F1
Moreno, A1
Serrate, G1
Claramonte, X1
Martos Rodríguez, A1
Mensa, J1
Ribot, T1
Sanfeliu, I1
Jiménez de Anta, MT1
Rørbakken, G1
Schulz, T1
Gracheva, NM1
Partin, OS1
Shcherbakov, IT1
Ivanova, VI1
Fokin, SN1
Leigh, DA1
Ahmad, F2
Prescott, RW1
Acquilla, S1
Lightfoot, NF2
Bíró, L1
Rókusz, L1
Szepesi, A1
Várszegi, J1
Nathwani, D1
Harvey, G1
Smith, CC1
Cowden, J1

Reviews

2 reviews available for ciprofloxacin and Gastroenteritis

ArticleYear
Antimicrobial therapy of acute diarrhoea: a clinical review.
    Expert review of anti-infective therapy, 2016, Volume: 14, Issue:2

    Topics: Acute Disease; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campyloba

2016
[Experience with ciprofloxacin therapy of salmonellosis gastroenteritica].
    Orvosi hetilap, 1992, Jan-26, Volume: 133, Issue:4

    Topics: Adolescent; Adult; Aged; Ciprofloxacin; Drug Evaluation; Female; Gastroenteritis; Humans; Middle Age

1992

Trials

4 trials available for ciprofloxacin and Gastroenteritis

ArticleYear
[Therapy of salmonella gastroenterocolitis].
    Medicinski pregled, 1994, Volume: 47, Issue:9-10

    Topics: Adolescent; Adult; Ampicillin; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Coliti

1994
Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 22, Issue:6

    Topics: Adult; Age Factors; Aged; Anti-Infective Agents; Campylobacter Infections; Ciprofloxacin; Community-

1996
[Antibiotic treatment of acute gastroenteritis].
    Revista clinica espanola, 1997, Volume: 197, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Aged; Amdinocillin Pivoxil; Anti-Infective Agents; Ciprofloxacin;

1997
[Experience with ciprofloxacin therapy of salmonellosis gastroenteritica].
    Orvosi hetilap, 1992, Jan-26, Volume: 133, Issue:4

    Topics: Adolescent; Adult; Aged; Ciprofloxacin; Drug Evaluation; Female; Gastroenteritis; Humans; Middle Age

1992

Other Studies

39 other studies available for ciprofloxacin and Gastroenteritis

ArticleYear
Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Anti-Bacterial Agents; Diarrhea; Dioxolanes; Fluoroquinolones; Gastroenteritis; Gram-Negative Bacter

2009
Campylobacter jejuni and Campylobacter coli in human stool samples: antibiotic resistance profiles, putative virulence determinants and molecular characterization of the isolates.
    World journal of microbiology & biotechnology, 2023, Oct-24, Volume: 39, Issue:12

    Topics: Anti-Bacterial Agents; Campylobacter; Campylobacter coli; Campylobacter Infections; Campylobacter je

2023
Etiology of childhood diarrhoea among under five children and molecular analysis of antibiotic resistance in isolated enteric bacterial pathogens from a tertiary care hospital, Eastern Odisha, India.
    BMC infectious diseases, 2019, Dec-02, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Infections; Child, Preschool; Ciprofloxacin; Cross-Sectional Studie

2019
Characterization of Campylobacter associated gastric enteritis among patients with Human Immunodeficiency Virus (HIV) in a hospital in Accra, Ghana.
    PloS one, 2020, Volume: 15, Issue:10

    Topics: Adult; Ampicillin; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Ciprofloxacin; Cr

2020
Two Unique Cases of Ciprofloxacin-Associated Avulsion of Ligament and Tendon.
    American journal of physical medicine & rehabilitation, 2018, Volume: 97, Issue:5

    Topics: Ciprofloxacin; Collateral Ligaments; Diverticulitis; Female; Gastroenteritis; Hamstring Tendons; Hum

2018
Antimicrobial resistance, virulence genes and genetic relatedness of Salmonella enterica serotype Enteritidis isolates recovered from human gastroenteritis in Tehran, Iran.
    Journal of global antimicrobial resistance, 2018, Volume: 12

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Feces; Gastroe

2018
Genetic diversity and clonal characteristics of ciprofloxacin-resistant Campylobacter jejuni isolated from Chilean patients with gastroenteritis.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2018, Volume: 58

    Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Chile; Ciprofloxacin; Drug Re

2018
Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey.
    Journal of medical microbiology, 2019, Volume: 68, Issue:2

    Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Diarrhea; Disk

2019
Quinolone and Macrolide-Resistant
    Microbial drug resistance (Larchmont, N.Y.), 2019, Volume: 25, Issue:7

    Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Child; Child, Preschool; Cipr

2019
Ciprofloxacin-induced psychosis.
    The Journal of neuropsychiatry and clinical neurosciences, 2014,Winter, Volume: 26, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Female; Gastroenteritis; Humans; Psychotic Disorders

2014
Campylobacter jejuni bacteraemia in a patient presenting with gastroenteritis.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2014, Volume: 24, Issue:9

    Topics: Administration, Intravenous; Adult; Bacteremia; Campylobacter Infections; Campylobacter jejuni; Cipr

2014
Methods to Study Antimicrobial Resistance in Campylobacter jejuni.
    Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1512

    Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Culture Media;

2017
[Bacterial diarrheas and antibiotics: European recommendations].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2008, Volume: 15 Suppl 2

    Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campylobacter Infections; Campylobacter j

2008
Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates.
    International microbiology : the official journal of the Spanish Society for Microbiology, 2010, Volume: 13, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bac

2010
[Acute gastroenteritis caused by a Vibrio cholerae non-O1, non-O139 strain harboring a genetic region homologous to the VpaI-7 pathogenicity island].
    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2011, Volume: 28, Issue:5

    Topics: Acute Disease; Anti-Infective Agents; Ciprofloxacin; Female; Gastroenteritis; Genomic Islands; Human

2011
Clinical characteristics and predictors of positive stool culture in adult patients with acute gastroenteritis.
    JPMA. The Journal of the Pakistan Medical Association, 2012, Volume: 62, Issue:1

    Topics: Acute Disease; Adult; Age Distribution; Campylobacter; Ciprofloxacin; Community-Acquired Infections;

2012
Refractory Salmonella enterica serotype choleraesuis-related renal cyst infection in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis treated successfully with intracystic ciprofloxacin infusion.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2012, Volume: 21, Issue:6

    Topics: Anti-Infective Agents; Ciprofloxacin; Cysts; Gastroenteritis; Humans; Male; Middle Aged; Polycystic

2012
Campylobacter gastroenteritis associated with Sweet's syndrome.
    Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 10

    Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Campylobacter Infections; Ciprofloxacin; Clob

2012
Non-typhoidal Salmonella gastroenteritis at a diarrheal hospital in Dhaka, Bangladesh, 1996-2011.
    The American journal of tropical medicine and hygiene, 2013, Volume: 88, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Bangladesh; Case-Control Studies; Child; Child,

2013
Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA,1982-2001.
    Emerging infectious diseases, 2002, Volume: 8, Issue:12

    Topics: Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin

2002
Influence of ciprofloxacin resistance on risk factors for endovascular infection in patients with infection due to group C nontyphoid salmonellae.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-01, Volume: 40, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Ciprofloxacin; Drug Resistance, Bacterial; F

2005
[Gastrointestinal infections. Economize with antibiotics!].
    MMW Fortschritte der Medizin, 2005, May-05, Volume: 147, Issue:18

    Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Diarrhea; Gastroenteritis; Humans; Metronidazole

2005
Genetic diversity of Campylobacter sp. isolates from retail chicken products and humans with gastroenteritis in Central Michigan.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:8

    Topics: Animals; Base Sequence; Campylobacter; Chickens; Ciprofloxacin; Drug Resistance, Bacterial; Gastroen

2005
In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to ciprofloxacin resistance.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:6

    Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resistanc

2005
Reduction in fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:3

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Finland; Gastroenteritis

2006
Optimizing use of ciprofloxacin: a prospective intervention study.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Drug Prescriptions; Drug Resis

2008
Salmonella gastroenteritis mimicking onset of inflammatory bowel disease in children.
    Journal of pediatric gastroenterology and nutrition, 2008, Volume: 46, Issue:1

    Topics: Abdominal Pain; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Colonoscopy; Diagnosi

2008
Low-level resistance to ciprofloxacin in non-Typhi Salmonella enterica isolated from human gastroenteritis in Dakar, Senegal (2004--2006).
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:6

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gastroenteritis; Humans; Microbial

2008
Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens.
    European journal of clinical microbiology, 1984, Volume: 3, Issue:4

    Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Gastroenteritis; Humans; Microbial Sensit

1984
[Bacteremia caused by quinolone-resistant Campylobacter jejuni in a patient with HIV infection].
    Enfermedades infecciosas y microbiologia clinica, 1994, Volume: 12, Issue:3

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Campylobacter Infec

1994
[Effect of ciprofloxacin therapy in duration of bacterial excretion in acute salmonella gastroenteritis].
    Schweizerische medizinische Wochenschrift, 1993, Oct-16, Volume: 123, Issue:41

    Topics: Adult; Ciprofloxacin; Colony Count, Microbial; Feces; Female; Gastroenteritis; Humans; Male; Middle

1993
Clinical audit of ciprofloxacin use in adults admitted to hospital with gastroenteritis.
    The Journal of infection, 1996, Volume: 33, Issue:1

    Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Female; Gastroenteritis; Humans; Male; Medical Au

1996
An audit of the clinical features and use of antimicrobials in adult diarrhoea.
    The Journal of infection, 1996, Volume: 32, Issue:1

    Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Drug Utilization; Feces; Gastroenteritis; Hum

1996
Splenic abscess caused by Salmonella braenderup, treated with percutaneous drainage and antibiotics.
    Scandinavian journal of infectious diseases, 1997, Volume: 29, Issue:4

    Topics: Abscess; Adolescent; Anti-Infective Agents; Catheterization; Ciprofloxacin; Female; Gastroenteritis;

1997
[Chemotherapy of Campylobacter infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1992, Volume: 37, Issue:6

    Topics: Adult; Age Factors; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciprofloxaci

1992
The treatment of a large outbreak of acute bacterial gastroenteritis with ciprofloxacin.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:5

    Topics: Acute Disease; Ciprofloxacin; Disease Outbreaks; Female; Gastroenteritis; Humans; Male; Salmonella e

1992
Management of a Salmonella outbreak in a geriatric hospital by ciprofloxacin therapy.
    The Journal of hospital infection, 1991, Volume: 18, Issue:1

    Topics: Aged; Aged, 80 and over; Ciprofloxacin; Disease Outbreaks; Gastroenteritis; Hospitals, Special; Huma

1991
Treatment of symptomatic enteric aeromonas hydrophila infection with ciprofloxacin.
    Scandinavian journal of infectious diseases, 1991, Volume: 23, Issue:5

    Topics: Aeromonas hydrophila; Aged; Aged, 80 and over; Ciprofloxacin; Disease Outbreaks; Female; Gastroenter

1991
Management of institutional outbreaks of Salmonella gastroenteritis.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26 Suppl F

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Contraindications; Cross Infection; Diarrhea; Disease Outbreak

1990